Eikon Therapeutics Inc.(EIKN:US)
Market Cap$401.71M
Key Metrics
Price$7.42
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$161.15M
Total Assets$850.83M
Net Assets$550.67M
Total Debt$254.83M
Key Metrics
Price$7.42
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$161.15M
Total Assets$850.83M
Net Assets$550.67M
Total Debt$254.83M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
| $87.34M | $83.17M | $71.38M | $67.78M | |
| Research and Development | $70.05M | $65.23M | $56.59M | $53.86M |
| Selling, General, and Administrative | $17.29M | $17.94M | $14.8M | $13.92M |
| Other Operating Expenses | - | - | - | - |
Operating Income | -$87.34M | -$83.17M | -$71.38M | -$67.78M |
| $4.38M | $3.51M | $3.14M | $2.85M | |
| Non-Operating Interest Income | $4.38M | $3.47M | $3.16M | $2.86M |
| Non-Operating Interest Expense | - | -$48K | - | $7K |
| Other Income/Expense | -$1K | -$9K | -$20K | $5K |
Income Before Tax | -$82.96M | -$79.66M | -$68.24M | -$64.92M |
Income Tax | - | - | - | - |
Net Income | -$82.96M | -$79.66M | -$68.24M | -$64.92M |
Minority Interests | - | - | - | - |
Preferred Stock Dividends | $0 | $0 | $6.3M | - |
Net Income to Common | -$82.96M | -$79.66M | -$74.54M | -$64.92M |
Shares Outstanding (Basic) | 33.7M | - | 32.71M | - |
Shares Outstanding (Diluted) | 33.7M | - | 32.71M | - |
EPS (Basic) | -$2.46 | - | -$2.28 | - |
EPS (Diluted) | -$2.46 | - | -$2.28 | - |
EBIT | -$87.34M | -$79.7M | -$71.38M | -$64.92M |
EBITDA | -$82.22M | -$74.6M | -$64.92M | -$58.7M |